Automated insulin reduces hypoglycaemia in elderly, enabling safer diabetes management for seniors- read to learn more.
9h
GlobalData on MSNFDA removes hold on vTv’s cadisegliatin clinical programme for diabetesLast July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the ...
Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality. I n 2024, a woman ...
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
There was also some evidence that the use of discreet devices, like those of the NovoPen ® family, facilitates adherence to intensive insulin therapy regimens, helps to improve lifestyle ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results